Meet our Scientific Advisory Board

The agenda is being shaped by an industry advisory board, with members including:

 

Professor Albert Osterhaus Professor Albert Osterhaus
Director, Research Center for Emerging Infections & Zoonoses (RIZ) 
University of Veterinary Medicine Hannover

Dr Jeffrey Almond Dr Jeffrey Almond
Former Vice President Discovery Research & Development, Sanofi & Visiting Professor  
University of Oxford - Oxford Vaccine Group

Dr Annaliesa Anderson Dr Annaliesa Anderson
VP Bacterial Vaccines
Pfizer

Dr Jan Poolman Dr Jan Poolman
Head Bacterial Vaccine Discovery & Early Development  
Janssen

Dr Gregory A. Poland Dr Gregory A. Poland 
Director of Mayo Vaccine Research Group  
Mayo Clinic and Foundation

Dr Antu Dey Dr Antu Dey
Senior Director, Research & Development  
International AIDS Vaccine Initiative

Konrad Stradler Dr Konrad Stadler
Head of R&D Vaccines  
Boehringer Ingelheim

Dr Roy Baynes Dr Roy Baynes
Senior Vice President Global Clinical Development & Chief Medical Officer  
MSD

Dr Nathalie Garçon Dr Nathalie Garçon 
CEO & CSO  
BIOASTER

Dr Cyril Gay   Dr Cyril Gay
Senior National Program Leader, Office of National Programs  
USDA

Dr Rino Rappuoli  Dr Rino Rappuoli
Chief Scientist  
GSK Vaccines

Dr Mahesh Kumar Dr Mahesh Kumar
Vice President, Global Biologics Research  
Zoetis

Dr Bernard Vallat Dr Bernard Vallat
Honorary Director General  
Office International Des Epizooties

Dr Ralf Clemens Dr Ralf Clemens
SVP
GRID Rio

Dr Jerald Sadoff Dr Jerald Sadoff  
Senior Advisor  
Janssen Infectious Diseases and Vaccines

Dr Lorne A. Babiuk Dr Lorne A. Babiuk
Former Vice-President
University of Alberta

Prof Roman Prymula Prof Roman Prymula
Professor Preventive Medicine
Charles University in Prague

Prof Hanna Nohynek Prof Hanna Nohynek 
Deputy Director
Finish Public Health

Prof Fred Zepp Prof Fred Zepp
Medical Director & Chairman of the Department of Paediatrics
University Medicine Mainz

Dr Joris Vandeputte Dr Joris Vandeputte
President 
IABS (International Alliance for Biological Standardization)

Prof Hanneke Schuitemaker

Prof Hanneke Schuitemaker 
Global Head of Viral Vaccine Discovery & Translational Medicine in the Infectious Disease & Vaccines Therapeutic Area 
Janssen Vaccines

Dr Helen Mcshane

Prof. Helen McShane  
Professor of Vaccinology
Oxford Martin School  

Dr Miles Carroll

Dr Miles Carroll 
Deputy Director 
Public Health England 

Dr Christiane Gerke, Head of Vaccine Programs, Institut Pasteur

Dr Christiane Gerke
Head of Vaccine Programs
Institut Pasteur

Dr Laszlo Radvanyi, President and Director, Ontario Institute For Cancer Research

Dr Laszlo Radvanyi  
President & Scientific Director
Ontario Institute for Cancer Research    

Egbert Mundt, Global Head of Vaccine Design R&D, Boehringer Ingelheim Animal Health

Egbert Mundt
Global Head of Vaccine Design R&D
Boehringer Ingelheim Animal Health